You are here

SEL-212

Sobi starts rolling FDA filing for chronic gout drug

Pharmaphorum

Tue, 07/2/24 - 11:14 am

Selecta narrows focus to gout drug, freezing rest of pipeline

Fierce Biotech

Thu, 08/17/23 - 10:15 am

Selecta Biosciences

Few signs of gout pipeline flaring up

EP Vantage

Thu, 05/18/23 - 10:45 am

Selecta Biosciences

Arthrosi Therapeutics

Atom Bioscience

Dyve Biosciences

Hinova Pharmaceuticals

Horizon Therapeutics

Jiangsu Hengrui Pharmaceuticals

Olatec Therapeutics

Shanton Bioscience

Selecta, Sobi rout gout in pair of phase 3 trials that could challenge Horizon

Fierce Biotech

Tue, 03/21/23 - 10:00 am

Selecta Biosciences

Horizon Therapeutics

Selecta lays off staff as R&D cash crunch looms

Fierce Biotech

Fri, 01/4/19 - 10:05 am

Selecta Biosciences

Polaris, Flagship, OrbiMed make it out with $70M IPO for Langer’s Selecta

Fierce Biotech

Thu, 06/23/16 - 08:24 pm

Selecta Biosciences